Biography:
Adam Istas is the Director of Thought Leadership for Quintiles, the only fully integrated bio and pharmaceutical services provider offering clinical, commercial, consulting and capital solutions. In this role, Adam is responsible for the development and dissemination of the organization’s intellectual capital, including the New Health Report – an annual survey of biopharmaceutical stakeholders. Prior to joining Quintiles, Adam was the editor-in-chief for Envisage magazine, a biopharmaceutical trade journal produced by Imagination Publishing in Chicago. Adam’s career in clinical research began in the Department of Neurology at Washington University in St. Louis School of Medicine, where he directed the research and production of the Stroke Trials Registry, an online, open-access registry of ongoing and completed clinical trials in stroke and cerebrovascular disease. He is a graduate of California State University, Fresno